Takeda Pharmaceutical Company Limited (4502.T) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Japan, listed on Tokyo. Market cap 9.33T JPY. 52-week range 4,102.00 to 6,033.00 JPY. Data as of 2026-10-11.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, ...